Acceso abierto

Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro

Rui Liu

Rui Liu

Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China
Buscar este autor en
Sciendo|Google Scholar
Liu, Rui
, 
Cuihong Jiang

Cuihong Jiang

Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China
Buscar este autor en
Sciendo|Google Scholar
Jiang, Cuihong
, 
Zhizheng Zhao

Zhizheng Zhao

Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China
Buscar este autor en
Sciendo|Google Scholar
Zhao, Zhizheng
, 
Yutong Lv

Yutong Lv

Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China
Buscar este autor en
Sciendo|Google Scholar
Lv, Yutong
 y 
Gaoxing Wang

Gaoxing Wang

Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China
Buscar este autor en
Sciendo|Google Scholar
Wang, Gaoxing
  
12 jun 2023
Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro's Cover Image
Acerca de este artículo
Artículo anterior
Artículo siguiente
Cite
Descargar portada
Publicado en línea: 12 jun 2023
Páginas: 269 - 280
Aceptado: 03 dic 2022
DOI: https://doi.org/10.2478/acph-2023-0015
Palabras clave
© 2023 Rui Liu et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Farmacia, Farmacia, otros
RSS Feed de revista